hero section gradient
11 handpicked stocks

Quantum Leap Investing

Dive into a collection of stocks at the forefront of quantum computing technology. These companies were carefully selected by our professional analysts for their potential to transform industries and create exponential growth opportunities in this revolutionary field.

Author avatar

Han Tan | Market Analyst

Published on May 12

Your Basket's Financial Footprint

Summary and investor takeaways based on the basket's market capitalisation breakdown.

Key Takeaways for Investors:
  • Large-cap dominance tends to reduce volatility, aligning returns more closely with broad-market movements and implying lower risk.
  • Consider this basket as a core holding for diversification, not a speculative small-cap growth play.
  • Expect steady, long-term appreciation rather than rapid, short-term gains; growth is generally measured and gradual.
Total Market Cap
  • NVDA: $4.40T

  • MSFT: $3.85T

  • GOOGL: $3.03T

  • Other

About This Group of Stocks

1

Our Expert Thinking

Quantum computing represents a fundamental shift in computational power that could solve problems thousands of times faster than today's technology. These stocks provide exposure to companies leading this paradigm shift across hardware, software, and enabling technologies with long-term transformative potential.

2

What You Need to Know

This collection balances pure-play quantum computing firms with established tech giants that have dedicated quantum divisions. The quantum computing market is still in its early stages, making these investments suited for those with a longer time horizon who can tolerate some volatility.

3

Why These Stocks

These companies were selected for their leadership positions in quantum development, strategic investments in the technology, and potential competitive advantages. Our analysts identified both specialized quantum innovators and larger corporations positioned to benefit from breakthroughs in this revolutionary field.

Why You'll Want to Watch These Stocks

🔮

The Future Is Quantum

These companies are developing technology that could solve 10,000-year problems in minutes. Getting in early could mean capturing extraordinary growth as quantum computing transforms entire industries.

🧩

Still Under The Radar

Quantum computing hasn't yet hit mainstream investor attention. This creates an opportunity to invest before the technology reaches its commercial tipping point and widespread adoption begins.

🚀

Multiple Growth Catalysts

From AI and drug discovery to cybersecurity and financial modeling, quantum breakthroughs could trigger growth across multiple sectors simultaneously. These stocks give you exposure to this potential multi-industry revolution.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

🚀

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions